ASAN FOUNDATION
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1989-06-23
- Employees
- 501
- Market Cap
- -
- Website
- https://ails.amc.seoul.kr
Pemetrexed and Cisplatin in Advanced Urothelial Carcinoma
Phase 2
Completed
- Conditions
- Urothelial Carcinoma
- Interventions
- First Posted Date
- 2011-12-13
- Last Posted Date
- 2014-09-25
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 42
- Registration Number
- NCT01490437
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Gemcitabine-Carboplatin Versus Gemcitabine-Oxaliplatin in Cisplatin-unfit Urothelial Carcinoma
Phase 2
- Conditions
- Advanced Urothelial Carcinoma
- Interventions
- Drug: GCbDrug: GemOx
- First Posted Date
- 2011-12-08
- Last Posted Date
- 2014-09-25
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 80
- Registration Number
- NCT01487915
- Locations
- 🇰🇷
Korea University Anam Hospital, Seoul, Korea, Republic of
🇰🇷Keimyeong University Dongsan Medical Center, Daegu, Korea, Republic of
🇰🇷Chungnam University Hospital, Daejeon, Korea, Republic of
The Role of Androgen Deprivation Treatment (ADT) in Docetaxe-Prednisolone Chemotherapy for Castrate-Resistant Prostatic Cancer
- First Posted Date
- 2011-12-08
- Last Posted Date
- 2011-12-08
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 90
- Registration Number
- NCT01487902
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
GEMOX in Docetaxel-Refractory Castration-Resistant Prostate Cancer
Phase 2
Completed
- Conditions
- Prostate Cancer
- Interventions
- Drug: GEMOX
- First Posted Date
- 2011-12-07
- Last Posted Date
- 2013-12-03
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 33
- Registration Number
- NCT01487720
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
RAD001 in Advanced Gastric Cancer Who Failed Standard First-line Treatment With pS6 Ser 240/4 Expression
- First Posted Date
- 2011-11-30
- Last Posted Date
- 2020-01-07
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 45
- Registration Number
- NCT01482299
- Locations
- 🇰🇷
Asan Medical Center, Songpa-gu, Seoul, Korea, Republic of
Prevalence of Metabolic Syndrome in Patients With Schizophrenia in Korea
- Conditions
- SchizophreniaMetabolic Syndrome
- First Posted Date
- 2011-11-23
- Last Posted Date
- 2011-11-23
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 1000
- Registration Number
- NCT01477918
- Locations
- 🇰🇷
Asan medical center, Seoul, Korea, Republic of
Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer
Phase 2
Completed
- Conditions
- Advanced Gastric Cancer
- Interventions
- Drug: Docetaxel, Capecitabine, Cisplatin, Bevacizumab
- First Posted Date
- 2011-11-15
- Last Posted Date
- 2020-01-07
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 31
- Registration Number
- NCT01471470
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Efficacy Study of Neoadjuvant Chemotherapy to Treat Advanced Ovarian Cancer
Phase 2
Completed
- Conditions
- Advanced Ovarian Cancer
- Interventions
- Drug: Neoadjuvant chemotherapy
- First Posted Date
- 2011-10-31
- Last Posted Date
- 2017-05-31
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 43
- Registration Number
- NCT01462149
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial Cancer
Phase 2
- Conditions
- Endometrial Cancer
- Interventions
- First Posted Date
- 2011-10-28
- Last Posted Date
- 2017-05-31
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 67
- Registration Number
- NCT01461746
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Efficacy Study of Chemotherapy to Treat Advanced or Recurrent Endometrial Cancer
- First Posted Date
- 2011-10-28
- Last Posted Date
- 2017-05-31
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 59
- Registration Number
- NCT01461759
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath